ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

An Appreciation: Leonard Erickson, 1946–2013

June 7, 2013

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

November 6, 2009

In Brief: NCI, EPA Award contract For Farmers study To Iowa, North Carolina; NIAID’s Hoth to Resign

January 29, 1993

NCI-Approved Clinical Trials

August 25, 2006

In Brief: Fredrickson Will Stay As NIH Director; NCI Group to Study Rhoads’ Clinical Center Idea

February 11, 1977

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010